Frank Thomas

Frank E.
Thomas is Chairman at Spero Therapeutics, Inc. since 2025.
Holds the position of Director at Orchard Therapeutics North America.
Serves as Independent Director at Larimar Therapeutics, Inc. since 2014.
President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd. since 2020.
President, Chief Operating & Financial Officer at Orchard Therapeutics Plc since 2018.
Former roles include President, Chief Executive Officer & Director at Critical Therapeutics, Inc. from 2006 to 2008.
Controller & Finance Director at Mechanical Dynamics, Inc. from 1997 to 2000.
Independent Director at Zafgen, Inc. Director at Massachusetts Biotechnology Council from 2007 to 2015.
Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc. from 2000 to 2004.
Chief Operating Officer & Senior Vice President at Molecular Biometrics, Inc. from 2010 to 2011.
Principal at Arthur Andersen LLP from 1992 to 2000.
President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate degree from the University of Michigan.